Dominic Sandhu, Snapper R M Magor-Elliott, Nayia Petousi, Nick P Talbot, Alexander N Bennett, David A Holdsworth, Grant A D Ritchie, Peter A Robbins
{"title":"健康个体和COVID-19感染康复个体的肺泡死腔和肺内分流","authors":"Dominic Sandhu, Snapper R M Magor-Elliott, Nayia Petousi, Nick P Talbot, Alexander N Bennett, David A Holdsworth, Grant A D Ritchie, Peter A Robbins","doi":"10.1113/EP092971","DOIUrl":null,"url":null,"abstract":"<p><p>Following acute COVID-19 infection, unvaccinated patients have been reported to exhibit elevated alveolar deadspace (̇V<sub>D,alv</sub>/̇V<sub>T</sub>) and intrapulmonary shunt (̇Q<sub>s</sub>/̇Q<sub>T</sub>) fractions. However, as there is uncertainty surrounding the upper limits of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub>, we sought to replicate the findings from a separate, previously reported cohort of COVID-19 patients that also included a healthy control group never infected with COVID-19. Data from 81 participants, classified into four different groups based on the severity of prior COVID-19 infection, were used. All participants had arterial blood-gas samples drawn while highly precise measurements of their respiratory gas exchange were made. The gas exchange data were used to estimate alveolar <math> <semantics><msub><mi>P</mi> <mrow><mi>C</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${P_{{\\mathrm{C}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> and <math> <semantics><msub><mi>P</mi> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${P_{{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> , and the differences between these values and the corresponding arterial blood-gas values provided the alveolar-arterial gradients from which ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub> were calculated. Mean ̇V<sub>D,alv</sub>/̇V<sub>T</sub> was 0.115 ± 0.062 and mean ̇Q<sub>s</sub>/̇Q<sub>T</sub> was 0.014 ± 0.011. No significant differences between the groups, including the uninfected control group, were detected for either ̇V<sub>D,alv</sub>/̇V<sub>T</sub> or ̇Q<sub>s</sub>/̇Q<sub>T</sub>, although if severity was instead treated as an interval measure, then a small increase in ̇Q<sub>s</sub>/̇Q<sub>T</sub> with severity (P = 0.00934) could be detected. Many participants, including controls, exceeded the originally proposed upper limit of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub>, whereas no participant exceeded the originally proposed upper limit for ̇Q<sub>s</sub>/̇Q<sub>T</sub>. We conclude that prior infection with COVID-19 had no effect on ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and little effect on ̇Q<sub>s</sub>/̇Q<sub>T</sub>, and that the supposedly high values of ̇V<sub>D,alv</sub>/̇V<sub>T</sub> are within the normal range.</p>","PeriodicalId":12092,"journal":{"name":"Experimental Physiology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Alveolar deadspace and intrapulmonary shunt in healthy individuals and in individuals who have recovered from COVID-19 infection.\",\"authors\":\"Dominic Sandhu, Snapper R M Magor-Elliott, Nayia Petousi, Nick P Talbot, Alexander N Bennett, David A Holdsworth, Grant A D Ritchie, Peter A Robbins\",\"doi\":\"10.1113/EP092971\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Following acute COVID-19 infection, unvaccinated patients have been reported to exhibit elevated alveolar deadspace (̇V<sub>D,alv</sub>/̇V<sub>T</sub>) and intrapulmonary shunt (̇Q<sub>s</sub>/̇Q<sub>T</sub>) fractions. However, as there is uncertainty surrounding the upper limits of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub>, we sought to replicate the findings from a separate, previously reported cohort of COVID-19 patients that also included a healthy control group never infected with COVID-19. Data from 81 participants, classified into four different groups based on the severity of prior COVID-19 infection, were used. All participants had arterial blood-gas samples drawn while highly precise measurements of their respiratory gas exchange were made. The gas exchange data were used to estimate alveolar <math> <semantics><msub><mi>P</mi> <mrow><mi>C</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${P_{{\\\\mathrm{C}}{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> and <math> <semantics><msub><mi>P</mi> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${P_{{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> , and the differences between these values and the corresponding arterial blood-gas values provided the alveolar-arterial gradients from which ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and ̇Q<sub>s</sub>/̇Q<sub>T</sub> were calculated. Mean ̇V<sub>D,alv</sub>/̇V<sub>T</sub> was 0.115 ± 0.062 and mean ̇Q<sub>s</sub>/̇Q<sub>T</sub> was 0.014 ± 0.011. No significant differences between the groups, including the uninfected control group, were detected for either ̇V<sub>D,alv</sub>/̇V<sub>T</sub> or ̇Q<sub>s</sub>/̇Q<sub>T</sub>, although if severity was instead treated as an interval measure, then a small increase in ̇Q<sub>s</sub>/̇Q<sub>T</sub> with severity (P = 0.00934) could be detected. Many participants, including controls, exceeded the originally proposed upper limit of normal for ̇V<sub>D,alv</sub>/̇V<sub>T</sub>, whereas no participant exceeded the originally proposed upper limit for ̇Q<sub>s</sub>/̇Q<sub>T</sub>. We conclude that prior infection with COVID-19 had no effect on ̇V<sub>D,alv</sub>/̇V<sub>T</sub> and little effect on ̇Q<sub>s</sub>/̇Q<sub>T</sub>, and that the supposedly high values of ̇V<sub>D,alv</sub>/̇V<sub>T</sub> are within the normal range.</p>\",\"PeriodicalId\":12092,\"journal\":{\"name\":\"Experimental Physiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental Physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1113/EP092971\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHYSIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1113/EP092971","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
Alveolar deadspace and intrapulmonary shunt in healthy individuals and in individuals who have recovered from COVID-19 infection.
Following acute COVID-19 infection, unvaccinated patients have been reported to exhibit elevated alveolar deadspace (̇VD,alv/̇VT) and intrapulmonary shunt (̇Qs/̇QT) fractions. However, as there is uncertainty surrounding the upper limits of normal for ̇VD,alv/̇VT and ̇Qs/̇QT, we sought to replicate the findings from a separate, previously reported cohort of COVID-19 patients that also included a healthy control group never infected with COVID-19. Data from 81 participants, classified into four different groups based on the severity of prior COVID-19 infection, were used. All participants had arterial blood-gas samples drawn while highly precise measurements of their respiratory gas exchange were made. The gas exchange data were used to estimate alveolar and , and the differences between these values and the corresponding arterial blood-gas values provided the alveolar-arterial gradients from which ̇VD,alv/̇VT and ̇Qs/̇QT were calculated. Mean ̇VD,alv/̇VT was 0.115 ± 0.062 and mean ̇Qs/̇QT was 0.014 ± 0.011. No significant differences between the groups, including the uninfected control group, were detected for either ̇VD,alv/̇VT or ̇Qs/̇QT, although if severity was instead treated as an interval measure, then a small increase in ̇Qs/̇QT with severity (P = 0.00934) could be detected. Many participants, including controls, exceeded the originally proposed upper limit of normal for ̇VD,alv/̇VT, whereas no participant exceeded the originally proposed upper limit for ̇Qs/̇QT. We conclude that prior infection with COVID-19 had no effect on ̇VD,alv/̇VT and little effect on ̇Qs/̇QT, and that the supposedly high values of ̇VD,alv/̇VT are within the normal range.
期刊介绍:
Experimental Physiology publishes research papers that report novel insights into homeostatic and adaptive responses in health, as well as those that further our understanding of pathophysiological mechanisms in disease. We encourage papers that embrace the journal’s orientation of translation and integration, including studies of the adaptive responses to exercise, acute and chronic environmental stressors, growth and aging, and diseases where integrative homeostatic mechanisms play a key role in the response to and evolution of the disease process. Examples of such diseases include hypertension, heart failure, hypoxic lung disease, endocrine and neurological disorders. We are also keen to publish research that has a translational aspect or clinical application. Comparative physiology work that can be applied to aid the understanding human physiology is also encouraged.
Manuscripts that report the use of bioinformatic, genomic, molecular, proteomic and cellular techniques to provide novel insights into integrative physiological and pathophysiological mechanisms are welcomed.